Bharat Biotech claims inability to provide vaccines to Delhi, alleges Manish Sisodia; accuses Centre of controlling supply
Supplies of Covaxin in Delhi are over and as a result, around 100 vaccination centres set up in 17 schools have been closed, Sisodia said
New Delhi: Deputy Chief Minister Manish Sisodia on Wednesday said Bharat Biotech has informed the Delhi government that it cannot provide "additional" Covaxin doses to the National Capital.
The stock of Covaxin in Delhi has finished and as a result around 100 vaccination centres set up in 17 schools have been closed, he said.
"The Covaxin manufacturer has in a letter said that it can not provide Delhi government vaccines due to unavailability, under the instruction of concerned government official. It means that the Central government is controlling supply of the vaccine," Sisodia said.
The deputy chief minister said Centre should stop the export of vaccines and share the vaccine formulae from the two manufacturers in the country with other companies for mass-scale production.
He also requested the Union government to approve vaccines available in international market for use in India, and to direct states to vaccinate everyone within three months.
A peer review of the jab is expected in two to four months after it was given to scientific journals, Raches Ella Project Lead COVID-19 Vaccines at Bharat Biotech said on Wednesday
Speaking on the occasion of Shiv Sena's foundation day, Thackeray said standing on one's own does not mean just fighting elections but fighting for rights.
Raches Ella, project lead COVID-19 Vaccines at Bharat Biotech said that there were nine publications on Covaxin so far and the efficacy paper on Phase-3 trials would be the tenth one